On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
FDA Approves Supplemental NDA for AbbVie's Viekira Pak Hepatitis C Drug
April 27th 2016The US Food and Drug Administration approved a supplemental New Drug Application submitted by drug maker AbbVie for Viekira Pak without ribavirin to treat patients with chronic hepatitis C genotype 1b and compensated cirrhosis.
The field of obstetrics and gynecology is constantly moving forward including new treatments for conditions like fibroids as well as work on new surgical treatments like uterine transplants. All these changes can present a wide range of challenges for health care professionals who work in this area of medicine.
Scott Chudnoff from Montefiore Medical Center: Developing New Treatments for Fibroids
As fibroids become a more common problem facing doctors and patients new treatment methods are being developed to address it. From new medications to various procedures these can allow patients to get the care they needed without affecting their quality of life as much as previous choices may have.